Search research articles
Contact Us
Filters
Showing results (231-240 of 261) with videos related to
Page
of 27
Sort By:
Journal of Cancer Epidemiology
|
May 12, 2011
Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control
Hextan Y S Ngan, Suzanne M Garland, Neerja Bhatla, et al.
Annals of Human Genetics
|
December 18, 2007
Evaluation of the NK2 homeobox 1 gene (NKX2-1) as a Hirschsprung's disease locus
M-M Garcia-Barceló, D K Lau, E S Ngan, et al.
Oncotarget
|
October 4, 2014
Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling
Patty C H Cai, Lei Shi, Vincent W S Liu, et al.
Oncogene
|
March 1, 2005
Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis
Fang Wang, Yu Zhu, Yan Huang, et al.
Oncogene
|
September 5, 2012
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
M K Y Siu, E S Y Wong, D S H Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2011
iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe
Lili Jiang, Michelle K Y Siu, Oscar G W Wong, et al.
Human Mutation
|
February 22, 2002
Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population
Ui-Soon Khoo, Kelvin Y K Chan, Annie N Y Cheung, et al.
Communications Biology
|
August 3, 2019
Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells
Rain R Chen, Mingo M H Yung, Yang Xuan, et al.
Plos One
|
November 21, 2014
Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance
Fung Zhao, Michelle K Y Siu, LiLi Jiang, et al.
Oncogene
|
September 1, 2018
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
Jing Sun, Xin Cai, Mingo Mh Yung, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 261) with videos related to
Sort By:
Page
of 27
Journal of Cancer Epidemiology
|
May 12, 2011
Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control
Hextan Y S Ngan, Suzanne M Garland, Neerja Bhatla, et al.
Annals of Human Genetics
|
December 18, 2007
Evaluation of the NK2 homeobox 1 gene (NKX2-1) as a Hirschsprung's disease locus
M-M Garcia-Barceló, D K Lau, E S Ngan, et al.
Oncotarget
|
October 4, 2014
Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling
Patty C H Cai, Lei Shi, Vincent W S Liu, et al.
Oncogene
|
March 1, 2005
Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis
Fang Wang, Yu Zhu, Yan Huang, et al.
Oncogene
|
September 5, 2012
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
M K Y Siu, E S Y Wong, D S H Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2011
iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe
Lili Jiang, Michelle K Y Siu, Oscar G W Wong, et al.
Human Mutation
|
February 22, 2002
Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population
Ui-Soon Khoo, Kelvin Y K Chan, Annie N Y Cheung, et al.
Communications Biology
|
August 3, 2019
Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells
Rain R Chen, Mingo M H Yung, Yang Xuan, et al.
Plos One
|
November 21, 2014
Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance
Fung Zhao, Michelle K Y Siu, LiLi Jiang, et al.
Oncogene
|
September 1, 2018
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
Jing Sun, Xin Cai, Mingo Mh Yung, et al.
Page
of 27